Oncolytic Virus R130（Yunying Medical）

N/A

Report date: 2024/07/29 16:54:36

Base Information

Drug NameOncolytic Virus R130（Yunying Medical）
Drug Alias NameRecombinant herpes simplex virus I（Yunying Medical）重组I型单纯疱疹病毒R130注射液（Vero细胞）Recombinant oncolytic herpes simplex virus type 1（Yunying Medical）R130R-130 +[6] 
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionAnti-CD3
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsSolid tumoursKidney NeoplasmsFallopian Tube Neoplasms +[28] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Yunying Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Yunying Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursKidney NeoplasmsFallopian Tube Neoplasms +[28] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A